This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Denka Company Limited, National Institute of Infectious Diseases, National Center for Geriatrics and Gerontology. Active years: 2022.
Company Filing History:
2 out of 386 
2 out of 37 
1 out of 25 
Years Active: 2022
Title: Reiko Todaka: Innovator in Norovirus Research
Introduction
Reiko Todaka is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of infectious diseases, particularly in the development of vaccines and screening methods for norovirus. With a total of 2 patents, her work is recognized for addressing critical challenges in immunization and research stagnation.
Latest Patents
Reiko Todaka's latest patents include a composite polypeptide monomer and an aggregate of said composite polypeptide monomer having cell penetration function. Additionally, she has developed a norovirus component vaccine designed for subcutaneous, intradermal, percutaneous, or intramuscular administration. This vaccine aims to readily immunize target cells and includes a molecular needle as an active ingredient. The invention also provides a cultured transgenic cell that allows for the growth of norovirus, addressing issues related to host specificity in mammalian cells.
Career Highlights
Throughout her career, Reiko Todaka has held significant positions, including Director-General of the National Institute of Infectious Diseases and a role at Denka Company Limited. Her leadership in these organizations has facilitated advancements in infectious disease research and vaccine development.
Collaborations
Reiko has collaborated with notable colleagues such as Kazuhiko Katayama and Motohiro Miki. These partnerships have contributed to her innovative research and the successful development of her patents.
Conclusion
Reiko Todaka's work in norovirus research exemplifies her dedication to advancing medical science and public health. Her innovative patents and leadership roles highlight her impact on the field of infectious diseases.